Ulisse Biomed S.p.A. (BIT:UBM)
Italy · Delayed Price · Currency is EUR 1.020
+0.020 (2.00%)
Nov 3, 2025, 2:38 PM CET
Ulisse Biomed Market Cap
Ulisse Biomed has a market cap or net worth of €24.85 million as of November 3, 2025. Its market cap has increased by 18.48% in one year.
Market Cap
24.85M
Enterprise Value
24.79M
Revenue
925.87K
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.02
Market Cap Chart
Since August 6, 2021, Ulisse Biomed's market cap has increased from 23.35M to 24.85M, an increase of 6.41%. That is a compound annual growth rate of 1.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 24.48M | 45.60% |
| Dec 30, 2024 | 16.81M | -52.90% |
| Dec 29, 2023 | 35.70M | 334.87% |
| Dec 30, 2022 | 8.21M | -65.95% |
| Dec 30, 2021 | 24.11M | 3.23% |
| Aug 6, 2021 | 23.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 10.62B |
| DiaSorin | 4.14B |
| Amplifon | 3.30B |
| Philogen | 998.55M |
| EL.En. | 908.29M |
| Safilo Group | 701.72M |
| Pharmanutra | 444.63M |
| Health Italia | 54.04M |